By Abdolghader Pakniyat, Peer-reviewed by Sabrina Berdouk

You’re about to intubate. The cuff cycles. The MAP is 45 and you know the three killers of intubation are hypoxia, hypotension and acidosis.

You need seconds—but you also need a plan, not a hero moment.

That’s the real niche for push-dose pressors (PDP):

PDP is a bridge for minutes. It buys time while you fix the cause, secure access, and get onto a continuous infusion strategy when indicated. If you’re repeatedly pushing, you’re not “managing shock”—you’re temporizing a system delay.

Push-dose pressors: indications, limits and risks

The upside

• Immediate rescue during peri-induction hypotension
• Bridge while infusions are being mixed/titrated and access is secured
• Lets you match physiology when you need a specific effect right now

The downside (this is where errors live)

• Preparation/dosing mistakes under stress
• Overshoot hypertension, tachyarrhythmias, ischemia
• The most dangerous trap: “BP looks better” while flow is worse

If your department uses PDP, standardize concentrations, labels and a local protocol. An ED observational study documented overdoses and adverse hemodynamic events. A transient rise in pressure does not establish improved patient outcomes.

The 10-second physiology that should drive the choice

Think like this:

MAP ≈ CO × SVR

So every push is a choice:

• Raise SVR (squeeze the pipes),
• Raise CO (support the pump),
• or some mix.

That’s why phenylephrine and epinephrine feel totally different at the bedside.

Phenylephrine PDP (“Neo”): squeeze the pipes

Mechanism: mostly α1 → vasoconstriction → ↑SVR. No direct inotropy.

When it’s a good match

Use phenylephrine when you suspect vasodilation with a reasonably intact pump, especially if you want to avoid β-stimulation:

• Selected hypotension with tachyarrhythmia: assess whether the rhythm is causing instability and prioritize indicated rhythm treatment. Pressor support must not substitute for cardioversion when indicated, even if LV systolic function appears preserved.
• Peri-induction vasodilation (the “anesthesia drop”)
• Dynamic LVOT obstruction/HOCM physiology (afterload helps; inotropy can hurt)

When it’s a bad match

Be cautious or avoid when:

• Bradycardia (reflex bradycardia can worsen)
• Low-output / weak LV (afterload ↑ can drop stroke volume)
• RV failure / pulmonary hypertension (phenylephrine can increase pulmonary arterial pressure and worsen RV loading)
• Biventricular failure (cardiogenic shock)

Typical adult bolus ranges vary by protocol (don’t freestyle concentrations).

Acute high-level spinal cord injury may cause hypotension with relative bradycardia. Phenylephrine can worsen bradycardia and reduce cardiac output. Norepinephrine is often selected on physiologic grounds, but the 2024 SCI guideline could not recommend a specific vasopressor because comparative evidence was insufficient. Individualize agent choice and sustained perfusion support; a rescue bolus must not replace that plan. SCI guideline.

Epinephrine PDP (“Epi”): squeeze + support the pump

Mechanism: α + β → vasoconstriction plus inotropy/chronotropy.

When it’s a good match

Epinephrine can provide temporary rate and contractility support in selected patients with critical hypotension. Choose it within the condition-specific plan; a weak LV alone is not an indication:

• Hypotension + bradycardia: rescue support must not delay the bradycardia pathway below.
• Low-output or mixed shock: individualize support. In infarct-related cardiogenic shock, an infusion trial found more refractory shock with epinephrine than norepinephrine. This does not directly compare rescue boluses. For septic shock with cardiac dysfunction, SSC 2026 conditionally suggests either agent as first-line vasopressor therapy, with very low-certainty evidence. This is not a bolus-dose recommendation.
• Anaphylaxis: give IM epinephrine first. Refractory anaphylaxis requires expert-led care and a titrated IV epinephrine infusion. Generic IV push-dose instructions should not replace that pathway. RCUK guidance.

When to be careful

• Tachyarrhythmias (you may accelerate the fire)
• Suspected LVOT obstruction (β1 inotropy can worsen obstruction)
• High ischemia risk where extra tachycardia is dangerous

Epinephrine can raise lactate. Reassess perfusion, rhythm and the underlying shock before attributing a rising lactate to the drug.

Norepinephrine bolus: clamp SVR, back up CO

Scope and preparation: Push-dose norepinephrine is off-label for the cited US products; their labels describe infusions. Use an approved local adult protocol specifying dose, concentration, volume, repeat interval and monitoring. Verify norepinephrine base-equivalent strength and the exact product’s compatible diluent. The cited concentrate recommends a dextrose-containing solution; ready-to-use saline bags are different formulations. Concentrate label; ready-to-use label.

Norepinephrine primarily increases vascular tone with some β1 activity; heart rate and cardiac output may still fall. Use ECG monitoring, frequent BP measurements and reassessment of perfusion. A small 2026 ED cohort reported hemodynamic adverse events despite standardized pre-diluted syringes. This conference abstract does not establish safety or an optimal dose. Ongoing shock needs a controlled infusion and cause-directed treatment.

Concentration check, not a prescription: 4 mg in a final volume of 250 mL is 16 micrograms/mL (4000 ÷ 250). At that concentration, 0.5 mL contains 8 micrograms and 1.25 mL contains 20 micrograms. This arithmetic does not validate a bolus regimen or a preparation procedure. Use the approved product and dose-volume chart rather than improvising serial dilutions.

Choosing a push-dose pressor by shock physiology

PDP pre-RSI quick pick

• Bradycardia with poor perfusion → follow the symptomatic-bradycardia algorithm. Treat reversible causes and use atropine, pacing, or an appropriate infusion as indicated. Rescue push-dose support under a local protocol must not delay these steps. (AHA ALS guidance)
• Tachyarrhythmia with hypotension → determine whether the rhythm is causing the instability. Provide prompt rhythm treatment, including synchronized cardioversion when indicated. A reassuring LV appearance does not remove that priority; pressors are secondary support.
• Depressed LV / low flow → reassess cause, rate and perfusion. Avoid reflex phenylephrine; choose rescue support and an infusion/inotrope strategy for the diagnosis.
• Confirmed dynamic LVOT obstruction → support preload when appropriate and consider phenylephrine; avoid increasing inotropy.
• RV strain / massive PE physiology → don’t default to phenylephrine; support RV and treat the cause
• Needing repeated pushes → establish an infusion promptly while maintaining perfusion.

That’s the whole game.

POCUS: how it helps you choose—and how it stops you from doubling down on the wrong drug

Do a minimum viable shock scan: LV, RV, pericardium, IVC, lungs (Pump + Tank + Pipes).

Pump (heart)

• Hyperdynamic small LV (“kissing”)
  This may reflect underfilling, vasodilation or dynamic obstruction. Combine it with Doppler findings, perfusion and the full shock assessment; heart rate and LV appearance alone should not choose the pressor. Original septic-shock study.
• Dilated/weak LV
  Phenylephrine can worsen stroke volume by increasing afterload.
  Select support from the full hemodynamic picture and cause; a weak LV does not automatically favor epinephrine.
• Big RV / RV strain
  Think obstructive/RV failure physiology. Treat the cause; choose support that preserves RV output.
• Dynamic LVOT obstruction clues (small LV, hyperdynamic, SAM/late-peaking Doppler if you’re measuring)
  Confirm the mechanism with Doppler when feasible. In obstructive HCM with hypotension unresponsive to fluids, guidance supports IV phenylephrine; avoid increasing inotropy.

Tank (volume/lungs)

• Collapsible/small IVC: interpret with breathing pattern, ventilation and the rest of the examination. Use an appropriate dynamic fluid-response assessment when feasible; do not treat the IVC alone as proof that more fluid will improve perfusion. ESICM shock monitoring guidance.
• B-lines/pulm edema: don’t reflexively pour fluid; match pressor/inotrope to pump.

Pipes (obstruction)

Tamponade, tension PTX, massive PE: PDP is not treatment—relieve the obstruction.

“BP improved ≠ flow improved”

Trend LVOT VTI with consistent acquisition alongside heart rate and clinical perfusion. Gross LV ejection alone does not measure forward cardiac output. ESICM shock monitoring guidance.

If you’re going to use VTI:

• keep the same view,
• average multiple beats,
• and interpret trends alongside HR/ventilation changes.

If phenylephrine raises cuff pressure but the heart looks more afterload-stressed and forward flow worsens, stop pushing phenylephrine. That’s not success; that’s a prettier number.

When to move from rescue boluses to an infusion

If you need repeated pushes, you’re late to an infusion and a diagnosis.
PDP is a bridge to the real plan—not the plan.

Four fast examples

1. Induction drop (warm, hyperdynamic LV)
   Vasodilation is possible; also assess underfilling and dynamic obstruction. Consider phenylephrine only if the overall physiology fits.
2. Brady hypotension / peri-arrest
   Follow the bradycardia algorithm; protocolized epinephrine rescue may bridge to pacing or infusion when indicated.
3. LVOT obstruction physiology
   Small hyperdynamic LV ± SAM raises suspicion; seek Doppler confirmation and treat the confirmed mechanism. Avoid increasing inotropy; assess preload.
4. Big RV + shock
   Think PE/RV failure → treat cause, support RV; don’t “phenylephrine your way” through RV collapse.

Take-home

• PDP is for minutes, not management.
• Ongoing shock or repeated rescue boluses: establish a controlled vasopressor infusion promptly when indicated, while treating the cause.
• Phenylephrine = SVR tool. Great when pump is okay and β is undesirable.
• Epinephrine supports vascular tone, rate and contractility, but use depends on the diagnosis and rhythm.
• POCUS helps identify physiology and trend response alongside clinical perfusion; it does not choose the drug by itself.
• Medication safety: use the approved adult local concentration and dose/volume chart, with clear labeling and an independent check.

Adult push-dose pressor safety checklist

Use an approved local adult drug and dose-volume chart. Prefer ready-to-administer, pharmacy-prepared syringes when available.

Confirm the drug, stock strength, final concentration, prescribed dose in micrograms and corresponding volume in millilitres. Independently check the preparation, label the syringe, confirm IV patency and inspect the site. Monitor ECG, measure BP frequently and reassess perfusion after each dose. Stop administration and manage suspected extravasation promptly under the local protocol. Follow that protocol for repeat dosing and escalation. Do not prepare IV-push medicines inside a commercially prefilled saline-flush syringe. See ISMP adult IV-push preparation safeguards.

Keep the condition-specific pathways above: push-dose support must not replace indicated pacing or cardioversion, and anaphylaxis requires its own adrenaline route and escalation pathway. See AHA adult ALS guidance and RCUK anaphylaxis guidance.

Educational content only. Follow local protocols, standard concentrations, and medication-safety practices.